Merajver SD - Search Results

1

Iniesta MD, Chien J, Wicha M, Merajver SD. Iniesta MD, et al. Among authors: merajver sd. Cancer Prev Res (Phila). 2010 Jan;3(1):12-5. doi: 10.1158/1940-6207.CAPR-09-0249. Cancer Prev Res (Phila). 2010. PMID: 20051368 Review.

2

Transcript identification in the BRCA1 candidate region.

Weber BL, Abel KJ, Couch FJ, Merajver S, Castilla L, Brody LC, Collins FS. Weber BL, et al. Breast Cancer Res Treat. 1995;33(2):115-24. doi: 10.1007/BF00682719. Breast Cancer Res Treat. 1995. PMID: 7749139 Free article. Review.

3

Familial breast cancer. Approaching the isolation of a susceptibility gene.

Weber BL, Abel KJ, Brody LC, Flejter WL, Chandrasekharappa SC, Couch FJ, Merajver SD, Collins FS. Weber BL, et al. Among authors: merajver sd. Cancer. 1994 Aug 1;74(3 Suppl):1013-20. doi: 10.1002/1097-0142(19940801)74:3+<1013::aid-cncr2820741507>3.0.co;2-#. Cancer. 1994. PMID: 8039134 Review.

4

Mammography of breast carcinoma in women who have mutations of the breast cancer gene BRCA1: initial experience.

Helvie MA, Roubidoux MA, Weber BL, Merajver SD. Helvie MA, et al. Among authors: merajver sd. AJR Am J Roentgenol. 1997 Jun;168(6):1599-602. doi: 10.2214/ajr.168.6.9168735. AJR Am J Roentgenol. 1997. PMID: 9168735

5

Breast conservation and prolonged chemotherapy for locally advanced breast cancer: the University of Michigan experience.

Merajver SD, Weber BL, Cody R, Zhang D, Strawderman M, Calzone KA, LeClaire V, Levin A, Irani J, Halvie M, August D, Wicha M, Lichter A, Pierce LJ. Merajver SD, et al. J Clin Oncol. 1997 Aug;15(8):2873-81. doi: 10.1200/JCO.1997.15.8.2873. J Clin Oncol. 1997. PMID: 9256131 Clinical Trial.

6

Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer.

Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, Chamberlain J, Boyd J, Garber JE, Collins FS, et al. Merajver SD, et al. Clin Cancer Res. 1995 May;1(5):539-44. Clin Cancer Res. 1995. PMID: 9816013

7

Treatment of metastatic cancer with tetrathiomolybdate, an anticopper, antiangiogenic agent: Phase I study.

Brewer GJ, Dick RD, Grover DK, LeClaire V, Tseng M, Wicha M, Pienta K, Redman BG, Jahan T, Sondak VK, Strawderman M, LeCarpentier G, Merajver SD. Brewer GJ, et al. Among authors: merajver sd. Clin Cancer Res. 2000 Jan;6(1):1-10. Clin Cancer Res. 2000. PMID: 10656425 Clinical Trial.

8

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.

Peterson EA, Milliron KJ, Lewis KE, Goold SD, Merajver SD. Peterson EA, et al. Among authors: merajver sd. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):79-87. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815404

9

Copper deficiency induced by tetrathiomolybdate suppresses tumor growth and angiogenesis.

Pan Q, Kleer CG, van Golen KL, Irani J, Bottema KM, Bias C, De Carvalho M, Mesri EA, Robins DM, Dick RD, Brewer GJ, Merajver SD. Pan Q, et al. Among authors: merajver sd. Cancer Res. 2002 Sep 1;62(17):4854-9. Cancer Res. 2002. PMID: 12208730

10

BRCA1 regulates human mammary stem/progenitor cell fate.

Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. Liu S, et al. Among authors: merajver sd. Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1680-5. doi: 10.1073/pnas.0711613105. Epub 2008 Jan 29. Proc Natl Acad Sci U S A. 2008. PMID: 18230721 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

258 results

Search Page